Risk factors and drug resistance in early-onset neonatal group B streptococcal disease

Ying-Wei Wang1, Yao-Qiang Du2, Xiao-Lin Miao3

  • 1Department of Laboratory Medicine, Tiantai People's Hospital, Taizhou 317200, China.

Insights

Group B Streptococcus (GBS) causes serious neonatal infections in Western countries. While GBS is less frequently reported in neonates in China, this may reflect lower clinical interest rather than true incidence.

Area of Science:

  • Neonatal infections
  • Microbiology
  • Public Health

Background:

  • Group B Streptococcus (GBS) is a significant pathogen causing neonatal infections in organs like the brain, lungs, and eyes.
  • GBS infections are a leading cause of neonatal morbidity and mortality in the United States.
  • In China, GBS is primarily detected in adult urogenital and perinatal screenings, with rare reports of neonatal infections.

Purpose of the Study:

  • To investigate the reported incidence and clinical significance of neonatal Group B Streptococcus infections.
  • To compare the epidemiology of GBS infections in China with Western countries.

Main Methods:

  • Review of existing literature and clinical data on GBS detection in China and Western countries.
  • Analysis of reported neonatal GBS infection rates and associated morbidity/mortality.

Main Results:

  • GBS is a major cause of neonatal disease in Western nations.
  • Neonatal GBS infections are infrequently reported in China.
  • The lower incidence in China may be influenced by varying levels of clinical surveillance and diagnostic focus.

Conclusions:

  • While GBS is a critical neonatal pathogen globally, its reported prevalence in China appears lower than in Western countries.
  • Further research is needed to ascertain the true incidence of neonatal GBS disease in China, considering potential disparities in clinical awareness and reporting.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
988
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
558